UPDATE : Monday, September 7, 2020
상단여백
Gilead launches new, improved hepatitis B drug by Marian Chu 2017-05-25 10:29
Hanmi ranked No. 1 in R&D investment by Lee Hye-seon 2017-05-24 14:19
Korean drugmakers challenge Pfizer’s smoking cessation therapy Champix by Lee Hye-seon 2017-05-24 13:16
FDA approves 1st cancer drug for tumors with particular genetic feature by Marian Chu 2017-05-24 12:37
Rising demand for cosmeceuticals forces pharmaceuticals to jump into cosmetics market by Constance Williams 2017-05-24 11:35
라인
Approvals of incrementally modified drugs poured in last year by Lee Hye-seon 2017-05-23 10:55
Ildong confident of its hepatitis drug surviving market competition by Marian Chu 2017-05-23 10:33
Will Korea’s first stem cell therapy pass reexamination? by Nam Doo-hyun 2017-05-22 13:43
No more calls for drug price hikes based on inaccurate statistics: MOHW by Nam Doo-hyun 2017-05-19 15:13
Celltrion launches anti-blood cancer biosimilar in Germany by Constance Williams 2017-05-18 17:00
라인
Hanmi wins approval for 1st asthma-rhinitis combination drug by Constance Williams 2017-05-17 17:32
Young children of pharmaceutical firms’ owners have shares by Nam Doo-hyun 2017-05-17 17:18
Ildong Pharmaceutical develops its first new drug by Lee Hye-seon 2017-05-17 14:42
Sanofi, LG Chemical in court battle over Zemiglo by Lee Hye-seon 2017-05-16 16:41
P2 trial over for GemVax’s prostate disease drug by Marian Chu 2017-05-15 11:00
라인
‘Korean pharmaceuticals should expand US export with new drugs’ by Nam Doo-hyun 2017-05-11 17:18
Roche’s bladder cancer drug fails P3 trial by Constance Williams 2017-05-11 16:25
Celltrion adds reason why Remsima can target US market by Constance Williams 2017-05-11 11:50
Investors focus on Moon-related shares by Nam Doo-hyun 2017-05-10 20:02
FDA gives accelerated approval to bladder cancer drug by Constance Williams 2017-05-10 11:11
여백
여백
여백
Back to Top